Skip to main content
. 2020 Oct;9(5):1354–1362. doi: 10.21037/gs-20-341

Table 3. Cohort baseline characteristics of studying prognosis of breast cancer with ISLN metastasis.

Variables Total, n (%)
Age, years
   <50 49 (57.6)
   ≥50 36 (42.4)
Menopause
   No 45 (52.9)
   Yes 40 (47.1)
Clinical T stage
   T1–2 62 (72.9)
   T3–4 23 (27.1)
ER
   Negative 30 (35.3)
   Positive 55 (64.7)
PR
   Negative 36 (42.4)
   Positive 49 (57.6)
HER2
   Negative 60 (70.6)
   Positive 25 (29.4)
aPCR
   No 54 (63.5)
   Yes 31 (36.5)
bPCR
   No 66 (77.6)
   Yes 19 (22.4)
sPCR
   No 41 (48.2)
   Yes 44 (51.8)